Despite great advancements in the treatment of moderate-to-severe psoriasis in clinical practice using biologics targeting Interleukin (IL)-17A, IL-23, and Tumor Necrosis Factor (TNF-), among others, mild psoriasis is typically managed with topical agents (e.g., corticosteroids, vitamin D analogs) due to their localized action and lower systemic toxicity
doi: 10.1016/j.mad.2011.02.007
Nayan Patel [00:46:05]: And if you look at the stories I get, I get every single day, my phones, I get emails on my phones from my staff
doi: 10.1210/en.2006-1540 91 KumarDCandlishMPeriasamyVAvcuNMayerCBoehmU
Our body is run on peptides, she explains
It can be a useful, informal indicator of bioactivity